As medicine and technology evolve, understanding what moves a field forward becomes more than informational — it becomes critical. Leaders from industry and academia stressed this point during a panel discussion at the Dallas Leipzig conference and shared their insights on the interplay between regulation and innovation, and how changes underway could impact the U.S. device market.
At Baylor Scott & White The Heart Hospital – Plano, a team of physicians and healthcare professionals work together in a multidisciplinary way to provide quality outcomes for their patients. These teams can include cardiologists, cardiothoracic surgeons, nurse practitioners, radiologists, gerontologists, intensivists, hospitalists, pulmonologists, neurologists, research coordinators, social workers, chaplains, dietary teams, and pharmacologists — all working together to provide quality patient care.
North Texas played host to a major international cardiovascular conference, Dallas Leipzig 2018, on Dec. 13-15, 2018. The event, which was held in conjunction with the Leipzig Heart Center in Germany, brought together world leaders in structural and valvular heart disease to discuss innovative concepts and observe some of the latest tools and techniques in action. The event’s agenda was specifically designed for, but not limited to, cardiothoracic surgeons, primary cardiologists, interventional cardiologists, anesthesiologists, nurses, technicians, nurse practitioners, perfusionists, cardiac imaging specialists and other healthcare providers of cardiovascular teams.
The Heart Hospital Baylor Plano is currently the only hospital in North Texas offering the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) as part of a pivotal study to evaluate its safety and efficacy. The TBE device is the first of its kind – designed for the endovascular treatment of aortic arch and descending thoracic aorta lesions in patients who are high risk for traditional surgery.
Baylor Scott & White The Heart Hospital – Plano is playing a key role in developing a first-of-its-kind wound imaging device equipped with artificial intelligence to noninvasively evaluate wounds and chronically ischemic limbs. The WISCR (Wound Imaging System to Collect Clinical References) study is collecting wound images and data to further develop the DeepView Wound Imaging System device.
